Offstream
news

---

Changes

1. Health Canada approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children aged 5 to 11 years old.
   2021-11-20 01:06:27 (First version)
2. Health Canada approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years.
   (Current version)

---

Related

Swissmedic approves the extension of booster doses of the Pfizer–BioNTech COVID-19 vaccine to people over the age of 16 years as well as high-risk people over the age of 12 years.
2021-11-23

Health Canada authorizes the use of booster doses of the Pfizer–BioNTech COVID-19 vaccine for people over the age of 18.
2021-11-9

People over the age of 75 in Vermont can now register to receive a booster shot of the Pfizer–BioNTech COVID-19 vaccine.
2021-09-27

Pfizer says that their vaccine candidate is effective for children between the ages of 5 and 11 years.
2021-09-20

The United Kingdom signs an agreement with Pfizer to secure 35 million doses of the Pfizer-BioNTech COVID-19 vaccine due to be delivered in the second half of 2022 as the government focuses on a "future-proof vaccine programme" to prevent any virus variants that are resistant to the vaccine.
2021-08-23

Prime Minister Jacinda Arden's Cabinet grants approval for children between the ages of 12 and 15 to receive the Pfizer–BioNTech vaccine beginning on September 1.
2021-08-19

The U.S. Food and Drug Administration authorizes a booster dose of the Pfizer–BioNTech and Moderna COVID-19 vaccines for immunocompromised people.
2021-08-12

The German Standing Committee on Vaccination recommends that only children and teenagers with pre-existing illness conditions be given a dose of the Pfizer-BioNTech COVID-19 vaccine due to lack of data on the vaccine's long-term effects.
2021-06-10

The Medicines and Healthcare products Regulatory Agency approves the usage of the Pfizer–BioNTech COVID-19 vaccine for people between the ages of 12 and 15, making it the first vaccine to be approved for use in teenagers in the UK.
2021-06-4

Health Canada approves the use of the Pfizer–BioNTech vaccine for children ages 12 to 15, becoming the first country to approve the vaccine for use in younger age groups.
2021-05-5